Skip to main content
. 2009 Dec 30;6(1):12–18. doi: 10.1200/JOP.091058

Table 2.

12-Month Average Cost by Pathway Status

Charge Category 12-Month Average Cost ($)
Comparison of Cost
On Pathway (n = 1,095) Off Pathway (n = 314) Cost Difference ($; on − off) Cost Ratio (on/off) 95% CI* for Cost Ratio
Outpatient visits 1,124 1,060 64 1.06 0.99 to 1.11
Acute care visits 437 364 73 1.20 0.95 to 1.46
Chemotherapy 11,839 18,762 −6,923 0.63 0.55 to 0.76
Other medication 4,374 7,198 −2,824 0.61 0.52 to 0.74
    ESAs 1,011 1,867 −856 0.54 0.42 to 0.69
    CSFs 1,867 2,951 −1,083 0.63 0.52 to 0.83
Laboratory procedures 223 295 −73 0.75 0.67 to 0.84
Minor procedures 33 43 −10 0.78 0.66 to 0.92
Nursing care/hospice 2.68 2.16 0.52 1.24 0.14 to 15.20
Other 1.25 0.99 0.25 1.25 0.39 to 9.04
G codes 7.86 11.94 −4.08 0.66 0.40 to 1.27
Total cost 18,042 27,737 −9,695 0.65 0.58 to 0.76

Abbreviations: ESA, erythropoietin stimulating agent; CSF, WBC growth factor.

*

95% CIs calculated using percentile method using 10,000 bootstrap samples.